Arrhythmogenic Right Ventricular Cardiomyopathy

  • Cristina Basso
    the Departments of Pathology and Cardiology, University of Padua Medical School, Padua, Italy.
  • Gaetano Thiene
    the Departments of Pathology and Cardiology, University of Padua Medical School, Padua, Italy.
  • Domenico Corrado
    the Departments of Pathology and Cardiology, University of Padua Medical School, Padua, Italy.
  • Annalisa Angelini
    the Departments of Pathology and Cardiology, University of Padua Medical School, Padua, Italy.
  • Andrea Nava
    the Departments of Pathology and Cardiology, University of Padua Medical School, Padua, Italy.
  • Marialuisa Valente
    the Departments of Pathology and Cardiology, University of Padua Medical School, Padua, Italy.

書誌事項

タイトル別名
  • Dysplasia, Dystrophy, or Myocarditis?

説明

<jats:p> <jats:italic>Background</jats:italic> Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a frequent cause of sudden death in young individuals and athletes. Although familial occurrence has been documented and a gene defect was recently localized on chromosome 14q23-q24 the etiopathogenesis of the disease is still obscure. </jats:p> <jats:p> <jats:italic>Methods and Results</jats:italic> A pathological study was conducted in 30 hearts with ARVC (age range, 15 to 65 years; mean, 28 years). In the 27 autopsy cases, the mode of death was sudden in 24 and congestive heart failure in 3. ECG, available in 19 cases, showed inverted T waves in the right precordial leads in 15 cases (79%) and ventricular arrhythmias in 15 (79%). Right ventricular aneurysms were present in 15 hearts (50%) and located in the inferior wall in 12. Left ventricle and ventricular septum were involved in 14 (47%) and 6 (20%) cases, respectively. Scattered foci of lymphocytes with myocardial death were observed in 20 cases (67%). Electron microscopy studies, although confirming the myocardial death and lymphocyte infiltrates, did not show any specific ultrastructural substrate. Two pathological patterns, fatty (40%) and fibrofatty (60%), were identified. The fibrofatty pattern was associated with a thinner right ventricular wall ( <jats:italic>P</jats:italic> <.0001) and a higher occurrence of focal myocarditis ( <jats:italic>P</jats:italic> <.001). In sections of right ventricular free wall with maximal fatty infiltration, the mean percentage area of fatty tissue was 35.9±11.1% in control versus 80.4±9.6% in the ARVC, fatty variety ( <jats:italic>P</jats:italic> <.00001). Involvement of the left ventricle and/or ventricular septum, right ventricular aneurysms, and inflammation were found almost exclusively in the fibrofatty variety. </jats:p> <jats:p> <jats:italic>Conclusions</jats:italic> In the fibrofatty variety of ARVC, the myocardial atrophy appears to be the consequence of acquired injury (myocyte death) and repair (fibrofatty replacement), mediated by patchy myocarditis. Whether the inflammation is a primary event or a reaction to spontaneous cell death remains unclear. </jats:p>

収録刊行物

  • Circulation

    Circulation 94 (5), 983-991, 1996-09

    Ovid Technologies (Wolters Kluwer Health)

被引用文献 (14)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ